title: [Extracorporeal partial nephrectomy under pharmaco-cold ischemia for renal cell carcinoma].
abstract: OBJECTIVE
  To develop the method for extracorporeal partial nephrectomy under pharmaco-cold ischemia without ureter intersection with orthotopic replantation of renal vessels for RCC.
  
  
  METHODS
  The study included 37 patients with morphologically confirmed RCC pT1a-Т3bN0M0-1G1-3 with intraparenchymal and central location of the tumor in cases of single kidney, comorbidity of contralateral kidney and kidney on the side of lesion.
  
  
  RESULTS
  Mean surgery time was 413.97±89.14 minutes. Mean time of warm ischemia was 8.39±4.75 minutes, cold ischemia - 151.41±41.29 minutes. Intraoperative and postoperative complications were detected in 3 (8.1%) and 18 (48.6%) patients respectively.
  
  
  CONCLUSIONS
  Extracorporeal partial nephrectomy under pharmaco-cold ischemia without ureter intersection with orthotopic replantation of renal vessels for RCC is a relatively safe organ-sparing treatment. It provides resection of large tumors with any location under prolonged cold ischemia without ureter intersection.
authors.affiliation: Vishnevsky Institute of Surgery Ministry of Health of the Russian Federation, Moscow, Russia.
authors.forename: A A
authors.initials: AA
authors.lastname: Gritskevich
authors.affiliation: Vishnevsky Institute of Surgery Ministry of Health of the Russian Federation, Moscow, Russia.
authors.forename: I V
authors.initials: IV
authors.lastname: Miroshkina
authors.affiliation: Vishnevsky Institute of Surgery Ministry of Health of the Russian Federation, Moscow, Russia.
authors.forename: S S
authors.initials: SS
authors.lastname: Piyanikin
authors.affiliation: Vishnevsky Institute of Surgery Ministry of Health of the Russian Federation, Moscow, Russia.
authors.forename: Z A
authors.initials: ZA
authors.lastname: Adyrkhayev
authors.affiliation: Vishnevsky Institute of Surgery Ministry of Health of the Russian Federation, Moscow, Russia.
authors.forename: Yu A
authors.initials: YA
authors.lastname: Stepanova
authors.affiliation: Vishnevsky Institute of Surgery Ministry of Health of the Russian Federation, Moscow, Russia.
authors.forename: A E
authors.initials: AE
authors.lastname: Zotikov
authors.affiliation: Vishnevsky Institute of Surgery Ministry of Health of the Russian Federation, Moscow, Russia.
authors.forename: A A
authors.initials: AA
authors.lastname: Teplov
authors.affiliation: Vishnevsky Institute of Surgery Ministry of Health of the Russian Federation, Moscow, Russia.
authors.forename: V A
authors.initials: VA
authors.lastname: Kubyshkin
authors.affiliation: Vishnevsky Institute of Surgery Ministry of Health of the Russian Federation, Moscow, Russia.
authors.forename: A Sh
authors.initials: AS
authors.lastname: Revishvili
mesh_terms: D002292:Carcinoma, Renal Cell / Q000473:pathology / Q000601:surgery; D050377:Cold Ischemia / Q000379:methods*; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D009392:Nephrectomy / Q000009:adverse effects / Q000379:methods; D059351:Organ Sparing Treatments / Q000379:methods*; D010043:Outcome and Process Assessment, Health Care; D011183:Postoperative Complications / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D012426:Russia